Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer

Patient Educ Couns. 2011 Apr;83(1):64-72. doi: 10.1016/j.pec.2010.05.025. Epub 2010 Jun 26.

Abstract

Objective: This study aimed to develop and pilot test an online screening decision aid (DA) for men with a family history of prostate cancer.

Methods: Eligible men (with no previous prostate cancer diagnosis) were recruited through relatives attending a urology outpatient clinic. Men evaluated the DA in two stages. First, they appraised a paper-based version using a questionnaire (n=22). Second, the same men were asked to reflect on an interactive web-based version via a semi-structured telephone interview (n=20).

Results: Men evaluated both forms of the DA positively. Of the paper-based version, the majority of participants found the DA useful (91%), and that it contained enough information to make a screening decision (73%). All participants reported that the online DA was easy to use and navigate. Most participants reported that a website was their preferred mode of receiving prostate cancer screening information (70%).

Conclusion: The developed DA may represent the first online decision-making tool designed specifically for men with a family history prostate cancer that presents age and risk specific information to the user.

Practice implications: Comprehensive evaluations of the efficacy and impact of educational interventions such as this are crucial to improve services for individuals making informed screening decisions.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Decision Making*
  • Decision Support Techniques*
  • Genetic Predisposition to Disease
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Internet*
  • Male
  • Markov Chains
  • Mass Screening
  • Middle Aged
  • Pilot Projects
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis*
  • Surveys and Questionnaires

Substances

  • Prostate-Specific Antigen